Brazil To Break Patent On Abbott Drug In Ten Days
Brazil has informed Abbott Laboratories that it will break the company's patent on the antiretroviral drug Kaletra in the next few days unless the U.S. drug maker offers a steep price...To view the full article, register now.
Already a subscriber? Click here to view full article